Jack Anders's most recent trade in Revolution Medicines Inc was a trade of 2,170 Common Stock done at an average price of $39.8 . Disclosure was reported to the exchange on June 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.83 per share. | 16 Jun 2025 | 2,170 | 113,314 (0%) | 0% | 39.8 | 86,431 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.04 per share. | 17 Mar 2025 | 1,864 | 115,006 (0%) | 0% | 39.0 | 72,771 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 71,400 | 71,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 20,400 | 116,870 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 45.40 per share. | 16 Dec 2024 | 2,635 | 96,470 (0%) | 0% | 45.4 | 119,639 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.68 per share. | 11 Oct 2024 | 10,000 | 108,932 (0%) | 0% | 2.7 | 26,800 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 10,000 | 2,814 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.30 per share. | 11 Oct 2024 | 10,000 | 98,932 (0%) | 0% | 50.3 | 502,979 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.19 per share. | 16 Sep 2024 | 2,244 | 98,932 (0%) | 0% | 44.2 | 99,152 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 17 Jun 2024 | 1,893 | 101,176 (0%) | 0% | 37.4 | 70,775 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.68 per share. | 03 May 2024 | 10,000 | 111,959 (0%) | 0% | 2.7 | 26,800 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 40.03 per share. | 03 May 2024 | 10,000 | 101,959 (0%) | 0% | 40.0 | 400,260 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 10,000 | 12,814 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 31.58 per share. | 18 Mar 2024 | 1,261 | 101,959 (0%) | 0% | 31.6 | 39,826 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 92,400 | 92,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 26,400 | 103,220 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.90 per share. | 18 Dec 2023 | 1,775 | 76,416 (0%) | 0% | 25.9 | 45,976 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 24.89 per share. | 20 Jun 2023 | 1,249 | 55,094 (0%) | 0% | 24.9 | 31,089 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.78 per share. | 17 Mar 2023 | 665 | 55,233 (0%) | 0% | 21.8 | 14,484 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 93,100 | 93,100 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 26,600 | 55,898 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.94 per share. | 19 Dec 2022 | 658 | 29,298 (0%) | 0% | 22.9 | 15,095 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.04 per share. | 19 Sep 2022 | 449 | 29,956 (0%) | 0% | 19.0 | 8,550 | Common Stock |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jack Anders | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 10,000 | 30,405 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Jack Anders | See Remarks | Sale of securities on an exchange or to another person at price $ 17.75 per share. | 17 Jun 2022 | 406 | 20,405 (0%) | 0% | 17.7 | 7,206 | Common Stock |
| Revolution Medicines Inc | Jack Anders | See Remarks | Sale of securities on an exchange or to another person at price $ 18.62 per share. | 17 Mar 2022 | 159 | 19,875 (0%) | 0% | 18.6 | 2,960 | Common Stock |
| Revolution Medicines Inc | Jack Anders | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 40,600 | 40,600 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jack Anders | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 11,600 | 20,034 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Jack Anders | See Remarks | Sale of securities on an exchange or to another person at price $ 30.02 per share. | 17 Sep 2021 | 166 | 8,192 (0%) | 0% | 30.0 | 4,983 | Common Stock |
| Revolution Medicines Inc | Jack Anders | See Remarks | Sale of securities on an exchange or to another person at price $ 34.12 per share. | 17 Jun 2021 | 160 | 8,358 (0%) | 0% | 34.1 | 5,460 | Common Stock |
| Revolution Medicines Inc | Jack Anders | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 25,900 | 25,900 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jack Anders | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 7,400 | 7,904 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Jack Anders | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.68 per share. | 13 Oct 2020 | 10,000 | 10,000 (0%) | 0% | 2.7 | 26,800 | Common Stock |
| Revolution Medicines Inc | Jack Anders | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2020 | 10,000 | 62,201 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jack Anders | See Remarks | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 13 Oct 2020 | 10,000 | 0 (0%) | 0% | 44 | 440,000 | Common Stock |
| Revolution Medicines Inc | Jack Anders | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2020 | 10,000 | 72,201 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Jack Anders | See Remarks | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 06 Oct 2020 | 10,000 | 0 (0%) | 0% | 40 | 400,000 | Common Stock |
| Revolution Medicines Inc | Jack Anders | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.68 per share. | 06 Oct 2020 | 10,000 | 10,000 (0%) | 0% | 2.7 | 26,800 | Common Stock |